Editas Medicine, Inc.
EDIT
$2.37
$0.2612.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 110.82% | -23.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 110.82% | -23.19% | |||
| Cost of Revenue | 22.21% | -39.15% | |||
| Gross Profit | 2.94% | 42.54% | |||
| SG&A Expenses | -4.22% | -3.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.51% | -27.34% | |||
| Operating Income | 3.59% | 27.89% | |||
| Income Before Tax | 52.82% | 30.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 52.82% | 30.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 52.82% | 30.03% | |||
| EBIT | 3.59% | 27.89% | |||
| EBITDA | -0.84% | 29.24% | |||
| EPS Basic | 55.80% | 31.15% | |||
| Normalized Basic EPS | 13.33% | 24.18% | |||
| EPS Diluted | 55.80% | 31.15% | |||
| Normalized Diluted EPS | 13.33% | 24.18% | |||
| Average Basic Shares Outstanding | 6.73% | 1.63% | |||
| Average Diluted Shares Outstanding | 6.73% | 1.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||